Angiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI)

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Patschan, Daniel ^a   Rinneburger, Jörg ^a   Idrizi, Nazif ^a   Backhaus, Rico ^a   Schwarze, Katrin ^a   Henze, Elvira ^a   Patschan, Susann ^a   Müller, Gerhard A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

AKI; Angiopoietin 1; eEOCs

Indexed keywords

ANGIOPOIETIN 1; CREATININE; INTERLEUKIN 6; LIPOCORTIN 5; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL HOMING; CELL MIGRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MONONUCLEAR CELL; MOUSE; NEPHRECTOMY; NONHUMAN; RENAL ARTERY; RENAL PROTECTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ACUTE KIDNEY INJURY; ANGIOPOIETIN-1; ANIMALS; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; ISCHEMIA; KIDNEY; MALE; MICE; MICE, INBRED C57BL; TREATMENT OUTCOME;

EID: 84885758451     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-227     Document Type: Article

References (35)

1. Acute renal failure - an review. Kribben A, Herget-Rosenthal S, Pietruck F, Philipp T, Dtsch Med Wochenschr 2003 128 22 1231 1236 12772081
2. Use of novel renal biomarkers for early detection of acute kidney injury-pro. Feldkamp T, Kribben A, Dtsch Med Wochenschr 2010 135 24 1250 10.1055/s-0030-1255146 20533161
3. Acute kidney injury. Kellum JA, Crit Care Med 2008 36 4 Suppl 141 S145 18382185
4. Update on mechanisms of ischemic acute kidney injury. Devarajan P, J Am Soc Nephrol 2006 17 6 1503 1520 10.1681/ASN.2006010017 16707563
5. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Patschan D, Krupincza K, Patschan S, Zhang Z, Hamby C, Goligorsky MS, Am J Physiol Renal Physiol 2006 291 1 176 F185 10.1152/ajprenal.00454.2005 16478972
6. Isolation of putative progenitor endothelial cells for angiogenesis. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, Science 1997 275 5302 964 967 10.1126/science.275. 5302.964 9020076
7. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, Tarnok A, Gielen S, Emmrich F, Schuler G, et al. Arterioscler Thromb Vasc Biol 2004 24 4 684 690 10.1161/01.ATV.0000124104.23702. a0 14988094
8. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM, Circ Res 1999 85 3 221 228 10.1161/01.RES.85.3.221 10436164
9. Endothelial progenitor cells. Khakoo AY, Finkel T, Annu Rev Med 2005 56 79 101 10.1146/annurev.med.56.090203.104149 15660503
10. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA, Redwood SR, Pearson JD, Marber MS, Circulation 2004 109 24 2986 2992 10.1161/01.CIR.0000130639.97284.EC 15184289
11. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Rafii S, Lyden D, Nat Med 2003 9 6 702 712 10.1038/nm0603-702 12778169
12. Endothelial progenitor cells: characterization and role in vascular biology. Urbich C, Dimmeler S, Circ Res 2004 95 4 343 353 10.1161/01.RES. 0000137877.89448.78 15321944
13. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Assmus B, Fischer-Rasokat U, Honold J, Seeger FH, Fichtlscherer S, Tonn T, Seifried E, Schächinger V, Dimmeler S, Zeiher AM, Circ Res 2007 100 8 1234 1241 10.1161/01.RES.0000264508.47717.6b 17379833
14. Transcoronary transplantation of progenitor cells after myocardial infarction. Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, et al. N Engl J Med 2006 355 12 1222 1232 10.1056/NEJMoa051779 16990385
15. Effect of acute exercise on endothelial progenitor cells in patients with peripheral arterial disease. Shaffer RG, Greene S, Arshi A, Supple G, Bantly A, Moore JS, Parmacek MS, Emile RM, Vasc Med 2006 11 4 219 226 10.1177/1358863x06072213 17390544
16. Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Thurston G, Cell Tissue Res 2003 314 1 61 68 10.1007/s00441-003-0749-6 12915980
17. Increased vascularization in mice overexpressing angiopoietin-1. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD, Science 1998 282 5388 468 471 9774272
18. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Science 1997 277 5322 55 60 10.1126/science.277.5322.55 9204896
19. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface. Hansen TM, Singh H, Tahir TA, Brindle NP, Cell Signalling 2010 22 3 527 532 10.1016/j.cellsig. 2009.11.007 19922791
20. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA, Circ Res 2000 87 7 603 607 10.1161/01.RES.87.7.603 11009566
21. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation. Abdel-Malak NA, Mofarrahi M, Mayaki D, Khachigian LM, Hussain SNA, Arterioscler Thromb Vasc Biol 2009 29 2 209 216 10.1161/ATVBAHA.108.181073 19112164
22. Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury. Shi H, Patschan D, Dietz GPH, Bähr M, Plotkin M, Goligorsky MS, Am J Physiol Renal Physiol 2008 294 1 229 F235 18003856
23. The hormone Melatonin stimulates renoprotective effects of early outgrowth endothelial progenitor cells in acute ischemic kidney injury. Patschan D, Hildebrandt A, Rinneburger J, Wessels JT, Patschan SA, Becker JU, Henze E, Kruger A, Muller GA, Am J Physiol Renal Physiol 2012 302 1305 F1312 10.1152/ajprenal.00445.2011 22357919
24. Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury. Patschan D, Patschan S, Wessels JT, Becker JU, David S, Henze E, Goligorsky MS, Müller GA, Am J Physiol Renal Physiol 2010 298 1 78 F85 10.1152/ajprenal.00485.2009 19906949
25. Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. Patschan D, Patschan S, Gobe GG, Chintala S, Goligorsky MS, J Am Soc Nephrol 2007 18 5 1516 1524 10.1681/ASN.2006070759 17409313
26. Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ça ira. Patschan D, Plotkin M, Goligorsky MS, Curr Opin Pharmacol 2006 6 2 176 183 10.1016/j.coph.2005.10.013 16487748
27. Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease. Patschan D, Schwarze K, Lange A, Meise N, Henze E, Becker JU, Patschan S, Muller GA, Am J Physiol Renal Physiol 2013 305 3 314 F322 10.1152/ajprenal.00677.2012 23678046
28. Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competence. Patschan D, Patschan S, Muller GA, Int J Nephrol 2011 2011 828369 21603112
29. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Rehman J, Li J, Orschell CM, March KL, Circulation 2003 107 8 1164 1169 10.1161/01.CIR. 0000058702.69484.A0 12615796
30. Dysfunctional endothelial progenitor cells in chronic kidney disease. Goligorsky MS, Yasuda K, Ratliff B, J Am Soc Nephrol 2010 21 6 911 919 10.1681/ASN.2009111119 20395371
31. Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures. Pula G, Mayr U, Evans C, Prokopi M, Vara DS, Yin X, Astroulakis Z, Xiao Q, Hill J, Xu Q, et al. Circ Res 2009 104 1 32 40 19023133
32. Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool. Yasuda K, Khandare A, Burianovskyy L, Maruyama S, Zhang F, Nasjletti A, Goligorsky MS, Aging 2011 3 6 597 608 21705809
33. Angiopoietin-2 modulates eEOC-mediated renoprotection in AKI in a dose-dependent manner. Patschan D, Backhaus R, Elle HJ, Schwarze K, Henze E, Becker JU, Patschan S, Muller GA, J Nephrol 2013 26 4 667 674 10.5301/jn.5000255 23475469
34. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Togel F, Yang Y, Zhang P, Hu Z, Westenfelder C, Am J Physiol Renal Physiol 2008 295 1 315 F321 10.1152/ajprenal.00098.2008 18480180
35. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Yamamoto T, Tada T, Brodsky SV, Tanaka H, Noiri E, Kajiya F, Goligorsky MS, Am J Physiol Renal Physiol 2002 282 6 1150 F1155 11997332